SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Confirmation Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 ['the SEBI (DP) Regulations'] for the quarter ended September 30, 2022 SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Clarification - Increase In Volume
Clarification letter is attached SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Clarification sought from Sun Pharma Advanced Research Company Ltd
The Exchange has sought clarification from Sun Pharma Advanced Research Company Ltd on September 30, 2022, with reference to Movement in Volume.The reply is awaited. SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release dated 29-Sep-2022 titled "SPARC to provide Update on Clinical Programs and R&D Pipeline" SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Closure of Trading Window
As attached
Sun Pharma's innovation arm strives to complete Covid-hit clinical trials
SPARC focuses on discovery and research of novel drugs prioritised in three therapeutic areas i.e. oncology, neurology and immunology. According to the company, during FY22, SPARC raised $148 million to complete the ongoing clinical studies. SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results and Scrutinizer's Consolidated Report of 17th Annual General Meeting of the Company held on September 22, 2022 SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 17th Annual General Meeting of Sun Pharma Advanced Research Company Limited held on September 22, 2022 SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Submission Of Chairman'S Speech Delivered At The 17Th Annual General Meeting Of The Company
Chairman's Speech delivered at the 17th Annual General Meeting of the Company is attached 